Greater disease activity and higher proteinuria levels were associated with a greater risk for VTE among patients with LN.
Reviewed by Chaitra Ujjani, MD, Associate Professor, Division of Hematology and Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Venous thromboembolism (VTE)--deep vein thrombosis ...
Patients with multiple myeloma are at increased risk for blood clots, especially in the first 6 to 12 months after treatment initiation. Many physicians advise no more than a daily aspirin to avoid ...
Proof-of-concept trials confirm robust anti-clotting effects for Regeneron’s two mechanistically-distinct antibodies against factor XI, in ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Exposure to common cancer treatments within 3 months ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. ATLANTA — Patients in the RE-SONATE trial who extended ...
Varese, Italy - A new meta-analysis has found that cardiovascular risk factors such as obesity, hypertension, and diabetes are associated with venous thromboembolism (VTE) [1]. Dr Walter Ageno ...
Phase I Dose Escalation, Pharmacokinetic and Pharmacodynamic Study of Naptumomab Estafenatox Alone in Patients With Advanced Cancer and With Docetaxel in Patients With Advanced Non–Small-Cell Lung ...
The FDA has approved Fragmin, a low molecular weight heparin, for the treatment of symptomatic venous thromboembolism to reduce the recurrence of VTE in pediatric patients 1 month of age and older.
The results of the oral direct THRombin Inhibitor ximelagatran for Venous thromboEmbolism Treatment (THRIVE Treatment) phase 3 study show that ximelagatran, the first of a new class of oral direct ...
Peripheral blood samples were collected from all patients before treatment and DD levels were measured. Blood samples were drawn from an antecubital vein by atraumatic puncture into plastic tubes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback